| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mannkind Corporation (MNKD) has 17 insiders with recent SEC Form 4 filings, including 4 buys and 7 sells. MNKD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.03M | $3.99M | - | |
| CEO | 796.0K | $3.10M | - | |
| VP | 460.8K | $1.79M | - | |
| VP | 349.8K | $1.36M | - | |
| Other | 344.2K | $1.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | Thomson David64 | EVP Genl Counsel &Secretary | Sell | 95,576 | $4.68 | $447,754.44 | -11.5% | -3.6% | +2.3% | |
| May 5, 2023 | Castagna Michael55 | Chief Executive Officer | Sell | 10,000 | $4.00 | $40,000.00 | -0.5% | +18.7% | +10.9% | |
| Apr 3, 2023 | Castagna Michael55 | Chief Executive Officer | Sell | 10,000 | $4.13 | $41,287.00 | -0.5% | -3.6% | +4.4% | |
| Mar 1, 2023 | Castagna Michael55 | Chief Executive Officer | Sell | 10,000 | $5.27 | $52,748.00 | -0.5% | -8.3% | -14.9% | |
| Aug 29, 2022 | Thomson David64 | EVP Genl Counsel &Secretary | Sell | 7,000 | $3.67 | $25,690.00 | -1.0% | +22.2% | +29.4% | |
| Aug 22, 2022 | Galindo Alejandro61 | EVP Endocrine Business Unit | Sell | 4,615 | $3.85 | $17,770.82 | -0.3% | +11.4% | +17.6% | |
| Jul 31, 2022 | Binder Steven B.68 | Chief Financial Officer | Buy | 791 | $2.93 | $2,317.63 | +0.1% | -2.5% | +27.7% | |
| Jul 31, 2022 | Castagna Michael55 | Chief Executive Officer | Buy | 3,147 | $2.93 | $9,220.71 | +0.2% | -2.5% | +27.7% | |
| Jul 31, 2022 | Tross Stuart A71 | Chief People &Workpl Officer | Buy | 4,581 | $2.93 | $13,422.33 | +0.6% | -2.5% | +27.7% | |
| Jul 31, 2022 | Galindo Alejandro61 | EVP Endocrine Business Unit | Buy | 5,000 | $2.93 | $14,650.00 | +0.6% | -2.5% | +27.7% |